RECRUITING

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Talk to us

Conditions

Lung CancerGastrointestinal Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Official Title

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Quick Facts

Study Start:2024-05-14
Study Completion:2027-02-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06420206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
  2. 2. Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
  3. 3. Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
  4. 4. Participant has the ability to speak and write in English
  5. 5. Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent
  1. 1. Participant is already enrolled in hospice
  2. 2. Participant is comatose
  3. 3. Participant has severe intellectual disability
  4. 4. Participant has a history of dementia documented in the medical records
  5. 5. Participant has baseline communication barriers such as aphasia or deafness
  6. 6. Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
  7. 7. Participant is 18 years or older, currently cared for by pediatrics service
  8. 8. Pregnant women
  9. 9. Prisoners

Contacts and Locations

Study Contact

Ahmed Elsayem, MD,MPH
CONTACT
(713) 745-9911
aelsayem@mdanderson.org

Principal Investigator

Ahmed Elsayem, MD,MPH
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Ahmed Elsayem, MD,MPH, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-14
Study Completion Date2027-02-02

Study Record Updates

Study Start Date2024-05-14
Study Completion Date2027-02-02

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Cancer
  • Gastrointestinal Cancer